Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

The collaboration builds on successful pilot projects at the University of Texas Medical Branch (UTMB) and the University of Texas Health Science Center at San Antonio (UTHSCSA), now part of UT San ...

A Potential New Standard for First-Line HER2+ Advanced GEA* Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 status* High GEA burden ...

In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...

The FDA has granted breakthrough therapy designation (BTD) to sevabertinib (Hyrnuo, formerly BAY 2927088) for the first-line ...

For Māori, data sovereignty – or rangatiratanga over data about Māori – is not a technical term. It’s about ...

The scientist quit the CDC in protest after Trump-appointed Secretary of Health and Human Services Robert F. Kennedy Jr. removed every member of the Advisory Community on Immunization Practices.

That deadline passed with no public confirmation the ransom was paid – and while Manage My Health and government authorities ...

For patients with spinal cord injury (SCI), older age does not seem to affect neurologic recovery but is associated with ...

In 2025, Alzheimer’s research crossed a threshold. What once felt like a slow and uncertain struggle against an unforgiving ...

Ainos at the Edge, ScentAI Scaling AI Intelligence. HOUSTON, TX / ACCESS Newswire / January 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...